Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Table 1

From: SIDE effects associated with use of nevirapine in HIV treatment naïve patients with respect to baseline CD4 count

  Parameter Outcome
NVP lead in dose initiated patients   3647 (n)
  Male 2408(66.02%)
  Female 1239(33.97%)
Male with CD4 >400 cells/mm3 and initiated NVP lead in dose (n = 2408) 47(1.95%)
Female with CD4 >250 cells/mm3 and initiated NVP lead in dose (n = 1239) 112(9.03%)
NVP induced Rash Male (n = 47) 0
  Female (n = 112) 5(4.46%)
NVP induced Hepatitis Male (n = 47) 1(2.12%)
  Female (n = 112) 0
Male with CD4 <400 cells/mm3 and initiated NVP lead in dose (n = 2408) 1629(67.64%)
Female with CD4 <250 cells/mm3 and initiated NVP lead in dose (n = 1239) 838(67.63%)
NVP induced Rash Male (n = 1629) 19(1.16%)
  Female (n = 838) 15(1.78%)
NVP induced Hepatitis Male (n = 1629) 5(0.30%)
  Female (n = 838) 2(0.23%)